Also found in: Medical, Encyclopedia, Wikipedia.


Any of a group of DNA viruses of the family Papillomavirus that can cause warts and certain types of cancer in mammals.


(Biology) any of numerous viruses that cause the formation of papillomas


(ˌpæp əˈloʊ məˌvaɪ rəs)

n., pl. -rus•es.
a type of papovavirus, containing circular DNA, that causes papillomas, including genital warts.


n virus m del papiloma papilomavirus m; human — (HPV) virus m del papiloma humano (VPH), papilomavirus humano (PVH)
References in periodicals archive ?
Approximately 250,000 women die each year of cervical cancers caused by human papillomavirus (HPV) despite the currently available preventative vaccines.
com/research/8qrbzw/20152019_global) has announced the addition of the "2015-2019 Global Papillomavirus Diagnostic Testing Market: Emerging Opportunities and Growth Strategies" report to their offering.
RESEARCH IS currently being undertaken at the Centre for Public Health Research, Massey University, on human papillomavirus (HPV) immunisation--this may be of some interest to readers of Kai Tiaki Nursing New Zealand.
Prior Information Notice: Prior information notice for the provision of a human papillomavirus vaccine.
The first animal papillomavirus was described in 1933 by Richard Shope, who researched papillomata in "warty" wild cottontail rabbits.
In a cohort of men followed for up to four years, the incidence of new oral human papillomavirus (HPV) infection was low, and most infections cleared within a year.
I Human papillomavirus (HPV) is a common 1 sexually transmitted infection (STI) affecting * both men and women.
Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review.
Researchers at the University of Leeds found that the E7 protein is produced early in the lifecycle of the human papillomavirus (HPV) and blocks the body's natural defences against the uncontrolled division of cells that can lead to cancer.
High-risk human papillomavirus (HPV) incidence and clearance were evaluated in 999 men (776 HIV-negative and 223 HIV-positive) aged 15-49 years who participated in male circumcision trials in Rakai, Uganda.
The topics include the art and science of obtaining virion stocks for experimental human papillomavirus infections, the structure and associations of E6 oncoproteins, the viral deregulation of DNA damage responses, the induction of genomic instability by human papillomavirus oncoproteins, and the role of the immune system in adenoviruses and gene therapy.
Ninety-three percent of samples from symptomatic specimens tested positive for the presence of avipox (n = 23) or papillomavirus (n = 5).